Monoclonal antibodies in pediatric allergy
Vol. 4 No. 2 (2015), Articles
Vol. 4 No. 2 (2015)

Monoclonal antibodies in pediatric allergy

Articles
https://doi.org/10.7363/040232
Published 2015-10-27
Amelia Licari
Department of Clinical Surgical Diagnostic and Pediatric Sciences, University of Pavia, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
Riccardo Castagnoli
Department of Clinical Surgical Diagnostic and Pediatric Sciences, University of Pavia, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
Alessia Marseglia
Department of Clinical Surgical Diagnostic and Pediatric Sciences, University of Pavia, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
Chiara Bottino
Department of Clinical Surgical Diagnostic and Pediatric Sciences, University of Pavia, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
Giulia Corana
Department of Clinical Surgical Diagnostic and Pediatric Sciences, University of Pavia, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
Paola Guerini
Department of Clinical Surgical Diagnostic and Pediatric Sciences, University of Pavia, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
Arianna Zaroli
Department of Clinical Surgical Diagnostic and Pediatric Sciences, University of Pavia, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
Silvia Caimmi
Department of Clinical Surgical Diagnostic and Pediatric Sciences, University of Pavia, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
Gian Luigi Marseglia
Department of Clinical Surgical Diagnostic and Pediatric Sciences, University of Pavia, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
JPNIM Vol. 4 N. 2 - Cover
PDF

Keywords

monoclonal antibodies (mAbs)
severe asthma
chronic spontaneous urticaria
anti-IgE mAbs
omalizumab

How to Cite

Licari, A., Castagnoli, R., Marseglia, A., Bottino, C., Corana, G., Guerini, P., Zaroli, A., Caimmi, S., & Marseglia, G. L. (2015). Monoclonal antibodies in pediatric allergy. Journal of Pediatric and Neonatal Individualized Medicine (JPNIM), 4(2), e040232. https://doi.org/10.7363/040232
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver

Download Citation

Endnote/Zotero/Mendeley (RIS) BibTeX

Abstract

Production of monoclonal antibodies (mAbs) involving human-mouse hybrid cells was first described in 1970s, but these biologics are now used for a variety of diseases including cancers, autoimmune disorders and allergic diseases. The aim of this article is to review current and future applications of mAbs, in particular focusing on anti-IgE therapy, in the field of pediatric allergy.

 

Proceedings of the 11th International Workshop on Neonatology and Satellite Meetings · Cagliari (Italy) · October 26th-31st, 2015 · From the womb to the adult
Guest Editors: Vassilios Fanos (Cagliari, Italy), Michele Mussap (Genoa, Italy), Antonio Del Vecchio (Bari, Italy), Bo Sun (Shanghai, China), Dorret I. Boomsma (Amsterdam, the Netherlands), Gavino Faa (Cagliari, Italy), Antonio Giordano (Philadelphia, USA)

https://doi.org/10.7363/040232
PDF